Betaine and secondary events in an acute coronary syndrome cohort.
about
Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes PathogenesisAltered glucose metabolism and hypoxic response in alloxan-induced diabetic atherosclerosis in rabbits.Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational StudyAssessment of urinary betaine as a marker of diabetes mellitus in cardiovascular patientsThe metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathwayEvaluation of toxicological effects induced by tributyltin in clam Ruditapes decussatus using high-resolution magic angle spinning nuclear magnetic resonance spectroscopy: Study of metabolic responses in heart tissue and detection of a novel metabolIncreased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.Peroxisome Proliferator-Activated Receptor Activation is Associated with Altered Plasma One-Carbon Metabolites and B-Vitamin Status in Rats.1H-NMR Based Serum Metabolomics Study to Investigate Hepatoprotective Effect of Qin-Jiao on Carbon Tetrachloride-Induced Acute Hepatotoxicity in Rats.Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults.Plasma Concentrations and Dietary Intakes of Choline and Betaine in Association With Atrial Fibrillation Risk: Results From 3 Prospective Cohorts With Different Health Profiles.Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period.Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart diseasePlasma choline, smoking, and long-term prognosis in patients with stable angina pectoris
P2860
Q26823198-B779DFDE-7CEE-4E16-8E28-5E63A35E3279Q33565629-A76F5958-9249-42CC-A18E-E7DC25402B88Q34672965-FECC9D0D-3286-4273-A7D3-3D9F18FEC406Q34924389-45E99B48-C4BC-491E-8C1F-7BEB560CE795Q37235361-358F8D80-DE9D-4580-86F9-BF246FD9F3F5Q41681086-C2F32701-57F4-4390-815E-7911165FF8D5Q42616677-434407AE-9791-45ED-A6E4-987E825D4B03Q43066371-97E60B5E-E857-4DFB-BC20-0E76D7717ADAQ47138527-D0E9BC17-DFD9-4AAE-B19D-B6C2D0E4B4ECQ48239148-7975F543-05A8-4567-92CF-A827337C0D4BQ52591085-699E523C-277C-41E0-9565-96E3682331CBQ54247889-65B40559-EFE1-4EA0-9AD6-C19756206B9FQ59275973-727E8838-7F47-459D-97ED-3985F219962DQ59275976-4EFFC37F-FCAC-4EBE-9E49-435DD4C308A3
P2860
Betaine and secondary events in an acute coronary syndrome cohort.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Betaine and secondary events in an acute coronary syndrome cohort.
@ast
Betaine and secondary events in an acute coronary syndrome cohort.
@en
Betaine and secondary events in an acute coronary syndrome cohort.
@nl
type
label
Betaine and secondary events in an acute coronary syndrome cohort.
@ast
Betaine and secondary events in an acute coronary syndrome cohort.
@en
Betaine and secondary events in an acute coronary syndrome cohort.
@nl
prefLabel
Betaine and secondary events in an acute coronary syndrome cohort.
@ast
Betaine and secondary events in an acute coronary syndrome cohort.
@en
Betaine and secondary events in an acute coronary syndrome cohort.
@nl
P2093
P2860
P1433
P1476
Betaine and secondary events in an acute coronary syndrome cohort.
@en
P2093
A Mark Richards
Christopher M Frampton
Jane L Elmslie
Michael Lever
Peter M George
Sandy Slow
Stephen T Chambers
Wendy Atkinson
P2860
P304
P356
10.1371/JOURNAL.PONE.0037883
P407
P577
2012-05-23T00:00:00Z